Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | BAX | Q07812 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.32 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8885 | 0.83 | LTA4H (0.50) | LTA4HTSHRCA4KCNA3CA5A | |
| Hydrochloric Acid SCHEMBL693111 | 0.80 | LTA4H (0.47) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL29544396 | 0.78 | LTA4H (0.45) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL852456 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL4697871 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL4531186 | 0.74 | CA4 (0.43) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL4735958 | 0.74 | CA4 (0.50) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL365524 | 0.74 | LTA4H (0.41) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL449851 | 0.74 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL30602838 | 0.70 | LTA4H (0.38) | LTA4HTSHRCA4KCNA3CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230256413-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4129466-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20210220753-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| US-10974167-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| EP-2714225-B1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORP (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20200332028-A1 | CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASIC MOIETIES | WATERS TECHNOLOGIES CORPORATION | 2020-10-22 | — | — | US | disclosed |
| EP-3687652-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | Waters Technologies Corporation (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20190134604-A1 | POROUS MATERIALS WITH CONTROLLED POROSITY; PROCESS FOR THE PREPARATION THEREOF; AND USE THEREOF FOR CHROMATOGRAPHIC SEPARATIONS | WATERS TECHNOLOGIES CORPORATION | 2019-05-09 | — | — | US | disclosed |
| US-20190126241-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION | 2019-05-02 | — | — | US | disclosed |
| US-20190091606-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2019-03-28 | — | — | US | disclosed |
| US-20170242028-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION | 2017-08-24 | — | — | US | disclosed |
| US-9588130-B2 | Methods for quantifying polypeptides using mass spectrometry | WATERS TECHNOLOGIES CORPORATION (US) | 2017-03-07 | — | — | US | disclosed |
| US-20150087073-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION | 2015-03-26 | — | — | US | disclosed |
| US-20140338429-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-20 | — | — | US | disclosed |
| US-20130319086-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| WO-2013158277-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION (US) | 2013-10-24 | — | — | WO | disclosed |
| WO-2012166916-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION (US) | 2012-12-06 | — | — | WO | disclosed |
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| EP-2462188-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2012-06-13 | — | — | EP | disclosed |
| WO-2011017418-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | SPECC1L, SAMM50, RAB5IF | LTA4H 86/4885TSHR 3344/4885CA4 328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.